Top Considerations To Meet FDA Requirements For Packaging Cryogenically Frozen Advanced Therapies
Source: Thermo Fisher Scientific

US Food and Drug Administration (FDA) requirements specify that packaging and distribution systems must protect the agent from contamination and damage. In distributing cryogenically frozen advanced therapies, this includes protection from temperature shock.
Packaging and shipper rack design can play a significant part in either maintaining or interfering with correct handling and temperature requirements, in addition to adding inefficiencies.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
Thermo Fisher Scientific
This website uses cookies to ensure you get the best experience on our website. Learn more